Your browser doesn't support javascript.
loading
Identification of genotype-biochemical phenotype correlations associated with fructose 1,6-bisphosphatase deficiency.
Sakuma, Ikki; Nagano, Hidekazu; Hashimoto, Naoko; Fujimoto, Masanori; Nakayama, Akitoshi; Fuchigami, Takahiro; Taki, Yuki; Matsuda, Tatsuma; Akamine, Hiroyuki; Kono, Satomi; Kono, Takashi; Yokoyama, Masataka; Nishimura, Motoi; Yokote, Koutaro; Ogasawara, Tatsuki; Fujii, Yoichi; Ogawa, Seishi; Lee, Eunyoung; Miki, Takashi; Tanaka, Tomoaki.
Affiliation
  • Sakuma I; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Nagano H; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Hashimoto N; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Fujimoto M; Research Institute of Disaster Medicine, Chiba University, Chiba, 260-8670, Japan.
  • Nakayama A; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Fuchigami T; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Taki Y; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Matsuda T; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Akamine H; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Kono S; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Kono T; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Yokoyama M; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Nishimura M; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Yokote K; Department of Molecular Diagnosis, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Ogasawara T; Division of Laboratory Medicine and Clinical Genetics, Chiba University Hospital, Chiba, 260-8670, Japan.
  • Fujii Y; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine Chiba University, Chiba, 260-8670, Japan.
  • Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Lee E; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Miki T; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Tanaka T; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
Commun Biol ; 6(1): 787, 2023 07 28.
Article in En | MEDLINE | ID: mdl-37507476
Fructose-1,6-bisphosphatase (FBPase) deficiency, caused by an FBP1 mutation, is an autosomal recessive disorder characterized by hypoglycemic lactic acidosis. Due to the rarity of FBPase deficiency, the mechanism by which the mutations cause enzyme activity loss still remains unclear. Here we identify compound heterozygous missense mutations of FBP1, c.491G>A (p.G164D) and c.581T>C (p.F194S), in an adult patient with hypoglycemic lactic acidosis. The G164D and F194S FBP1 mutants exhibit decreased FBP1 protein expression and a loss of FBPase enzyme activity. The biochemical phenotypes of all previously reported FBP1 missense mutations in addition to G164D and F194S are classified into three functional categories. Type 1 mutations are located at pivotal residues in enzyme activity motifs and have no effects on protein expression. Type 2 mutations structurally cluster around the substrate binding pocket and are associated with decreased protein expression due to protein misfolding. Type 3 mutations are likely nonpathogenic. These findings demonstrate a key role of protein misfolding in mediating the pathogenesis of FBPase deficiency, particularly for Type 2 mutations. This study provides important insights that certain patients with Type 2 mutations may respond to chaperone molecules.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Acidosis, Lactic / Fructose-1,6-Diphosphatase Deficiency Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Commun Biol Year: 2023 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Acidosis, Lactic / Fructose-1,6-Diphosphatase Deficiency Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Commun Biol Year: 2023 Type: Article Affiliation country: Japan